CR2Cancer

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Domain, Function and Classification > Gene Ontology > KEGG and Reactome Pathway

> Domain, Function and Classification

[ TOP ]

Domain

PF00628 PHD-finger
PF14051 N-terminal domain of DPF2/REQ.

Function

Belongs to the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a post-mitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to post-mitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Muscle-specific component of the BAF complex, a multiprotein complex involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Specifically binds acetylated lysines on histone 3 and 4 (H3K14ac, H3K9ac, H4K5ac, H4K8ac, H4K12ac, H4K16ac). In the complex, it acts as a tissue-specific anchor between histone acetylations and methylations and chromatin remodeling. It thereby probably plays an essential role in heart and skeletal muscle development.

Classification

Class	Modification	Substrate	Product	PubMed
Chromatin remodelling	#	H3, H4	#	21423274

> Gene Ontology [ TOP ]
Biological Process	-
Molecular Function	-
Cellular Component	GO:0070603 SWI/SNF superfamily-type complex GO:0071565 nBAF complex GO:0090544 BAF-type complex

> KEGG and Reactome Pathway [ TOP ]
KEGG	-
Reactome	-

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Mutation landscape in primary tumor tissue from TCGA > Mutation landscape in cancer cell line from CCLE > All mutations from COSMIC database V81 > Variations from text mining

> The Cancer Genome Atlas (TCGA) [ TOP ]

> Cancer Cell Line Encyclopedia (CCLE) [ TOP ]
There is no record.

> Catalogue of Somatic Mutations in Cancer (COSMIC) [ TOP ]
There is no record for DPF3.

> Text Mining based Variations

[ TOP ]

PMID	Variation	Cancer	Evidence
16109180	Mutation	Breast Carcinoma	Polymorphisms in the 5' region of DPF3 were associated with increased risk of breast cancer development, lymph node metastases, age of onset, and tumor size in women of European ancestry.

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Post-translational modification (PTM)

> Post-translational modification (PTM) [ TOP ]
There is no PTM data

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Expression analysis in primary tumor tissue from TCGA > Expression level in cancer cell line from CCLE > Expression level in human normal tissue from HPA > Text mining based expression change

> The Cancer Genome Atlas (TCGA)

[ TOP ]

Differential expression analysis for cancers with more than 10 normal samples

Cancer	Full Name	# N	# T	Median (N)	Median (T)	LogFC	Adj. P	Status
BLCA	Bladder urothelial carcinoma	19	408	-0.203	-2.041	-1.641	6.3e-05	Under
BRCA	Breast invasive carcinoma	112	1100	0.093	-1.467	-1.59	5.97e-22	Under
CESC	Cervical and endocervical cancers	3	306	-2.419	-1.322	NA	NA	NA
COAD	Colon adenocarcinoma	41	459	2.714	-0.448	-3.082	3.41e-32	Under
ESCA	Esophageal carcinoma	11	185	0.111	-2.07	-1.94	0.00062	Under
GBM	Glioblastoma multiforme	5	166	2.771	3.884	NA	NA	NA
HNSC	Head and Neck squamous cell carcinoma	44	522	-0.35	-1.163	-1.215	1.38e-06	Under
KIRC	Kidney renal clear cell carcinoma	72	534	1.268	1.997	0.581	0.00443	Over
KIRP	Kidney renal papillary cell carcinoma	32	291	2.165	0.224	-1.487	4.2e-06	Under
LAML	Acute Myeloid Leukemia	0	173	NA	-1.185	NA	NA	NA
LGG	Brain Lower Grade Glioma	0	530	NA	3.474	NA	NA	NA
LIHC	Liver hepatocellular carcinoma	50	373	1.507	-1.043	-2.577	3.54e-20	Under
LUAD	Lung adenocarcinoma	59	517	-1.113	-1.222	-0.265	0.142	NS
LUSC	Lung squamous cell carcinoma	51	501	-0.963	-1.883	-0.996	4.04e-08	Under
OV	Ovarian serous cystadenocarcinoma	0	307	NA	1.089	NA	NA	NA
PAAD	Pancreatic adenocarcinoma	4	179	-0.098	-0.748	NA	NA	NA
PCPG	Pheochromocytoma and Paraganglioma	3	184	1.617	1.698	NA	NA	NA
READ	Rectum adenocarcinoma	10	167	2.323	-0.46	-2.829	1.64e-08	Under
SARC	Sarcoma	2	263	1.56	0.139	NA	NA	NA
SKCM	Skin Cutaneous Melanoma	1	472	0.681	-0.292	NA	NA	NA
STAD	Stomach adenocarcinoma	35	415	0.243	-0.902	-0.91	0.00026	Under
TGCT	Testicular Germ Cell Tumors	0	156	NA	0.174	NA	NA	NA
THCA	Thyroid carcinoma	59	509	-0.748	-0.681	0.09	0.516	NS
THYM	Thymoma	2	120	0.339	-0.384	NA	NA	NA
UCEC	Uterine Corpus Endometrial Carcinoma	35	546	-0.938	-1.667	-0.903	0.00176	Under

> Cancer Cell Line Encyclopedia (CCLE) [ TOP ]
There is no record.

> The Human Protein Atlas (HPA)

[ TOP ]

Tissue	Expression Level (TPM)
Adipose tissue	0.1
Adrenal gland	1.8
Appendix	0.7
Bone marrow	1.6
Breast	0.3
Cerebral cortex	7.4
Cervix, uterine	0.6
Colon	1.9
Duodenum	0.2
Endometrium	0.4
Epididymis	0.2
Esophagus	0.6
Fallopian tube	0.3
Gallbladder	0.4
Heart muscle	8.8
Kidney	1.5
Liver	1.6
Lung	0.4
Lymph node	1
Ovary	16.7
Pancreas	0
Parathyroid gland	10.1
Placenta	0.5
Prostate	0.2
Rectum	1.6
Salivary gland	0
Seminal vesicle	0.2
Skeletal muscle	9.1
Skin	0.5
Small intestine	1.1
Smooth muscle	0.8
Spleen	1
Stomach	0.4
Testis	3.1
Thyroid gland	0.3
Tonsil	1
Urinary bladder	0.2

> Text Mining based Expression [ TOP ]
There is no record.

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Somatic copy number alteration in primary tomur tissue

> The Cancer Genome Atlas (TCGA)

[ TOP ]

Correlation between expression and SCNA as well as percentage of patients in different status.

Cancer	Full Name	# Sample	R	P	% Loss	% Neutral	% Gain	Status
BLCA	Bladder urothelial carcinoma	404	0.179	0.000292	31.9	51.5	16.6	Neutral
BRCA	Breast invasive carcinoma	1075	0.098	0.00128	33	55.3	11.7	Neutral
CESC	Cervical and endocervical cancers	292	0.025	0.676	13.4	68.5	18.2	Neutral
COAD	Colon adenocarcinoma	449	0.247	1.16e-07	33.2	59.5	7.3	Neutral
ESCA	Esophageal carcinoma	183	0.172	0.0201	27.9	44.8	27.3	Neutral
GBM	Glioblastoma multiforme	147	0.414	1.92e-07	37.4	57.1	5.4	Loss
HNSC	Head and Neck squamous cell carcinoma	514	0.123	0.00509	11.5	57.6	30.9	Neutral
KIRC	Kidney renal clear cell carcinoma	525	0.251	5.17e-09	43.2	53.7	3	Loss
KIRP	Kidney renal papillary cell carcinoma	288	0.19	0.0012	17.4	81.9	0.7	Neutral
LAML	Acute Myeloid Leukemia	166	0.093	0.235	0	98.8	1.2	Neutral
LGG	Brain Lower Grade Glioma	513	0.441	8.06e-26	23.4	75.8	0.8	Neutral
LIHC	Liver hepatocellular carcinoma	364	0.412	2.59e-16	34.9	59.1	6	Loss
LUAD	Lung adenocarcinoma	512	0.183	2.97e-05	27.3	49	23.6	Neutral
LUSC	Lung squamous cell carcinoma	498	0.097	0.0305	36.5	38	25.5	Loss
OV	Ovarian serous cystadenocarcinoma	300	0.252	9.67e-06	48.7	38	13.3	Loss
PAAD	Pancreatic adenocarcinoma	177	0.141	0.0608	10.2	74	15.8	Neutral
PCPG	Pheochromocytoma and Paraganglioma	162	0.364	1.88e-06	14.8	82.1	3.1	Neutral
READ	Rectum adenocarcinoma	164	0.16	0.0401	41.5	52.4	6.1	Loss
SARC	Sarcoma	255	0.379	4.02e-10	31.4	46.7	22	Neutral
SKCM	Skin Cutaneous Melanoma	367	0.17	0.00106	33	56.1	10.9	Neutral
STAD	Stomach adenocarcinoma	413	0.224	4.15e-06	29.3	63.9	6.8	Neutral
TGCT	Testicular Germ Cell Tumors	150	0.415	1.28e-07	14	50	36	Gain
THCA	Thyroid carcinoma	497	0.111	0.0129	0.4	97.4	2.2	Neutral
THYM	Thymoma	119	-0.021	0.819	2.5	86.6	10.9	Neutral
UCEC	Uterine Corpus Endometrial Carcinoma	537	-0.015	0.732	13.4	78.4	8.2	Neutral

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Methylation level in the promoter region of CR

> Methylation level in the promoter region of CR

[ TOP ]

Correlation between expression and methylation as well as differential methylation analysis.

Cancer	Full Name	R	P	# N	# T	Delta beta (T vs N)	P value (T vs N)	Status
BLCA	Bladder urothelial carcinoma	-0.092	0.0579	17	408	-0.001	0.0413	NS/NA
BRCA	Breast invasive carcinoma	-0.21	4.94e-10	83	785	0.005	2.13e-27	NS/NA
CESC	Cervical and endocervical cancers	-0.21	0.000208	3	306	NA	NA	NS/NA
COAD	Colon adenocarcinoma	-0.131	0.0199	19	297	0.002	4.01e-05	NS/NA
ESCA	Esophageal carcinoma	-0.149	0.0382	9	185	NA	NA	NS/NA
GBM	Glioblastoma multiforme	-0.469	9.67e-05	1	64	NA	NA	NS/NA
HNSC	Head and Neck squamous cell carcinoma	-0.092	0.0316	20	522	0.008	5.76e-05	NS/NA
KIRC	Kidney renal clear cell carcinoma	-0.141	0.00911	24	319	0.008	0.956	NS/NA
KIRP	Kidney renal papillary cell carcinoma	-0.165	0.0043	23	275	0.013	3.92e-07	NS/NA
LAML	Acute Myeloid Leukemia	-0.24	0.00163	0	170	NA	NA	NS/NA
LGG	Brain Lower Grade Glioma	-0.205	2.01e-06	0	530	NA	NA	NS/NA
LIHC	Liver hepatocellular carcinoma	-0.283	5.35e-09	41	373	0.005	5.51e-12	NS/NA
LUAD	Lung adenocarcinoma	-0.1	0.0293	21	456	0.007	0.0631	NS/NA
LUSC	Lung squamous cell carcinoma	-0.102	0.0478	8	370	NA	NA	NS/NA
OV	Ovarian serous cystadenocarcinoma	-0.5	0.178	0	9	NA	NA	NS/NA
PAAD	Pancreatic adenocarcinoma	-0.228	0.00193	4	179	NA	NA	NS/NA
PCPG	Pheochromocytoma and Paraganglioma	-0.319	9.49e-06	3	184	NA	NA	NS/NA
READ	Rectum adenocarcinoma	-0.256	0.00979	2	99	NA	NA	NS/NA
SARC	Sarcoma	-0.289	2.07e-06	0	263	NA	NA	NS/NA
SKCM	Skin Cutaneous Melanoma	-0.141	0.00222	1	471	NA	NA	NS/NA
STAD	Stomach adenocarcinoma	-0.044	0.401	0	372	NA	NA	NS/NA
TGCT	Testicular Germ Cell Tumors	-0.198	0.0132	0	156	NA	NA	NS/NA
THCA	Thyroid carcinoma	-0.107	0.0114	50	509	-0.001	0.701	NS/NA
THYM	Thymoma	-0.077	0.401	2	120	NA	NA	NS/NA
UCEC	Uterine Corpus Endometrial Carcinoma	-0.045	0.338	34	431	-0.003	0.00407	NS/NA

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Primary tumor tissue from TCGA > Normal tumor tissue from HPA

>The Cancer Genome Atlas (TCGA) [ TOP ]
There is no record.

> The Human Protein Atlas (HPA)

[ TOP ]

Tissue	Level	Level Name
Adrenal gland	2	Medium
Appendix	1	Low
Bone marrow	1	Low
Breast	0	Not detected
Bronchus	0	Not detected
Caudate	2	Medium
Cerebellum	3	High
Cerebral cortex	3	High
Cervix, uterine	0	Not detected
Colon	1	Low
Duodenum	0	Not detected
Endometrium	0	Not detected
Epididymis	0	Not detected
Esophagus	0	Not detected
Fallopian tube	0	Not detected
Gallbladder	0	Not detected
Heart muscle	2	Medium
Hippocampus	1	Low
Kidney	1	Low
Liver	0	Not detected
Lung	0	Not detected
Lymph node	0	Not detected
Nasopharynx	0	Not detected
Oral mucosa	0	Not detected
Ovary	2	Medium
Pancreas	0	Not detected
Parathyroid gland	0	Not detected
Placenta	0	Not detected
Prostate	0	Not detected
Rectum	1	Low
Salivary gland	0	Not detected
Seminal vesicle	0	Not detected
Skeletal muscle	1	Low
Skin	1	Low
Small intestine	0	Not detected
Smooth muscle	0	Not detected
Soft tissue	0	Not detected
Spleen	0	Not detected
Stomach	0	Not detected
Testis	3	High
Thyroid gland	0	Not detected
Tonsil	0	Not detected
Urinary bladder	0	Not detected
Vagina	0	Not detected

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Association between expresson and subtype > Overall survival analysis based on expression > Association between expresson and stage > Association between expresson and grade

> Subtype

[ TOP ]

Association between expresson and subtype.

Cancer	Full Name	# Patients	P Value (Kruskal-Wallis)	Association	Source
BLCA	Bladder urothelial carcinoma	128	0.534	NS	24476821
BRCA	Breast invasive carcinoma	521	7.24e-23	Significant	23000897
COAD	Colon adenocarcinoma	149	0.0181	Significant	22810696
GBM	Glioblastoma multiforme	157	5.16e-09	Significant	26824661
HNSC	Head and Neck squamous cell carcinoma	279	2.07e-12	Significant	25631445
KIRP	Kidney renal papillary cell carcinoma	161	0.0915	NS	26536169
LGG	Brain Lower Grade Glioma	513	2.53e-10	Significant	26824661
LUAD	Lung adenocarcinoma	230	0.00493	Significant	25079552
LUSC	Lung squamous cell carcinoma	178	1.52e-09	Significant	22960745
OV	Ovarian serous cystadenocarcinoma	287	1.76e-07	Significant	21720365
READ	Rectum adenocarcinoma	67	0.981	NS	22810696
SKCM	Skin Cutaneous Melanoma	315	0.256	NS	26091043
STAD	Stomach adenocarcinoma	277	1.79e-10	Significant	25079317
THCA	Thyroid carcinoma	391	2.84e-07	Significant	25417114
UCEC	Uterine Corpus Endometrial Carcinoma	232	0.0177	Significant	23636398

> Overall survival

[ TOP ]

Overall survival analysis based on expression.

Cancer	Full Name	# Patients	Hazard Ratio	P Value (Log Rank Test)	Association
BLCA	Bladder urothelial carcinoma	405	1.013	0.954	NS
BRCA	Breast invasive carcinoma	1079	0.993	0.975	NS
CESC	Cervical and endocervical cancers	291	0.975	0.938	NS
COAD	Colon adenocarcinoma	439	1.056	0.854	NS
ESCA	Esophageal carcinoma	184	0.735	0.349	NS
GBM	Glioblastoma multiforme	158	1.064	0.817	NS
HNSC	Head and Neck squamous cell carcinoma	518	0.916	0.657	NS
KIRC	Kidney renal clear cell carcinoma	531	0.72	0.117	NS
KIRP	Kidney renal papillary cell carcinoma	287	0.384	0.0245	Longer
LAML	Acute Myeloid Leukemia	149	0.686	0.204	NS
LGG	Brain Lower Grade Glioma	511	1.48	0.119	NS
LIHC	Liver hepatocellular carcinoma	365	0.638	0.0628	NS
LUAD	Lung adenocarcinoma	502	0.757	0.173	NS
LUSC	Lung squamous cell carcinoma	494	0.797	0.237	NS
OV	Ovarian serous cystadenocarcinoma	303	0.814	0.328	NS
PAAD	Pancreatic adenocarcinoma	177	0.676	0.202	NS
PCPG	Pheochromocytoma and Paraganglioma	179	4.463	0.143	NS
READ	Rectum adenocarcinoma	159	0.284	0.0568	NS
SARC	Sarcoma	259	1.838	0.0305	Shorter
SKCM	Skin Cutaneous Melanoma	459	0.646	0.0189	Longer
STAD	Stomach adenocarcinoma	388	1.456	0.106	NS
TGCT	Testicular Germ Cell Tumors	134	765937163.795	0.113	NS
THCA	Thyroid carcinoma	500	0.385	0.218	NS
THYM	Thymoma	119	1.251	0.823	NS
UCEC	Uterine Corpus Endometrial Carcinoma	543	1.625	0.114	NS

> Stage

[ TOP ]

Association between expresson and stage.

Cancer	Full Name	# Patients	R Value (Spearman)	P Value (Spearman)	Association
BLCA	Bladder urothelial carcinoma	406	0.029	0.562	NS
BRCA	Breast invasive carcinoma	1071	-0.028	0.357	NS
CESC	Cervical and endocervical cancers	167	-0.09	0.249	NS
COAD	Colon adenocarcinoma	445	-0.043	0.365	NS
ESCA	Esophageal carcinoma	162	-0.041	0.603	NS
HNSC	Head and Neck squamous cell carcinoma	448	-0.172	0.000253	Lower
KIRC	Kidney renal clear cell carcinoma	531	0.056	0.194	NS
KIRP	Kidney renal papillary cell carcinoma	260	-0.149	0.0163	Lower
LIHC	Liver hepatocellular carcinoma	347	-0.102	0.0575	NS
LUAD	Lung adenocarcinoma	507	-0.109	0.0139	Lower
LUSC	Lung squamous cell carcinoma	497	-0.034	0.444	NS
OV	Ovarian serous cystadenocarcinoma	302	0.056	0.331	NS
PAAD	Pancreatic adenocarcinoma	176	-0.118	0.12	NS
READ	Rectum adenocarcinoma	156	0.098	0.224	NS
SKCM	Skin Cutaneous Melanoma	410	-0.045	0.368	NS
STAD	Stomach adenocarcinoma	392	0.057	0.263	NS
TGCT	Testicular Germ Cell Tumors	81	-0.327	0.0029	Lower
THCA	Thyroid carcinoma	499	-0.163	0.000261	Lower
UCEC	Uterine Corpus Endometrial Carcinoma	501	0.041	0.356	NS

> Grade

[ TOP ]

Association between expresson and grade.

Cancer	Full Name	# Patients	R Value (Spearman)	P Value (Spearman)	Association
CESC	Cervical and endocervical cancers	272	0.043	0.478	NS
HNSC	Head and Neck squamous cell carcinoma	498	0.02	0.651	NS
KIRC	Kidney renal clear cell carcinoma	525	0	0.993	NS
LGG	Brain Lower Grade Glioma	514	-0.005	0.908	NS
LIHC	Liver hepatocellular carcinoma	366	-0.228	1.05e-05	Lower
OV	Ovarian serous cystadenocarcinoma	296	-0.027	0.641	NS
PAAD	Pancreatic adenocarcinoma	176	-0.115	0.129	NS
STAD	Stomach adenocarcinoma	406	0.2	4.78e-05	Higher
UCEC	Uterine Corpus Endometrial Carcinoma	534	0.167	0.000107	Higher

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Targets inferred by reverse engineering method > Targets identified by ChIP-seq data

> Targets inferred by reverse engineering method [ TOP ]

> Targets identified by ChIP-seq data [ TOP ]

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Drugs from DrugBank database

> Drugs from DrugBank database [ TOP ]
There is no record for DPF3.

Summary
Symbol	DPF3
Name	double PHD fingers 3
Aliases	cer-d4; Cerd4; FLJ14079; BAF45c; BRG1-associated factor 45C; zinc finger protein cer-d4; Zinc finger protein ......
Location	14q24.2
External Links	HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases	ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content	> Protein-Protein Interaction Network > miRNA Regulatory Relationship > Interactions from Text Mining

> Protein-Protein Interaction Network [ TOP ]

> miRNA Regulatory Relationship [ TOP ]

> Interactions from Text Mining [ TOP ]
There is no record for DPF3.